MedTrace Logo

Safety Study of Plasma Treatment System to Treat Back Acne

NCT01662349 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-09-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of treating human skin with atmospheric plasma and get an initial evaluation of the efficacy of this treatment for acne.

Conditions

  • Acne Vulgaris

Interventions

DEVICE

MOE Antimicrobial Plasma Treatment System

Plasma applied to back for up to 20 minutes, twice/week for 4 weeks

Sponsors & Collaborators

  • Moe Medical Devices

    lead INDUSTRY

Principal Investigators

  • Alexandra B. Kimball, MD · Partners Healthcare System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01662349 on ClinicalTrials.gov